CONVERSION TO MYCOPHENOLATE MOFETIL COMBINED WITH LOW-DOSE OF CALCINEURIN INHIBITORS IN LIVER TRANSPLANT PATIENTS WITH CHRONIC RENAL DYSFUNCTION.

被引:0
|
作者
Cristina, Ponton E. [1 ]
Luis, Vizcaino [1 ]
Santiago, Tome [1 ]
Javier, Castroagudin [1 ]
Esteban, Otero [1 ]
Ester, Molina [1 ]
Jesus, Hermida [1 ]
Ana, Lopez [1 ]
Perez Evaristo, Varo [1 ]
机构
[1] Hosp Clin Univ, Abdominal Transplant Div, Dept Surg, Santiago, A Coruna, Spain
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S104 / S104
页数:1
相关论文
共 50 条
  • [1] Conversion to Combined Mycophenolate Mofetil and Low-Dose Calcineurin Inhibitor Therapy for Renal Dysfunction in Liver Transplant Patients: Never Too Late?
    Susanne Beckebaum
    Vito R. Cicinnati
    [J]. Digestive Diseases and Sciences, 2011, 56 : 4 - 6
  • [2] Conversion to Combined Mycophenolate Mofetil and Low-Dose Calcineurin Inhibitor Therapy for Renal Dysfunction in Liver Transplant Patients: Never Too Late?
    Beckebaum, Susanne
    Cicinnati, Vito R.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (01) : 4 - 6
  • [3] Efficacy and safety of a reduced calcineurin inhibitor dose combined with mycophenolate mofetil in liver transplant patients with chronic renal dysfunction
    Wang, Pusen
    Que, Weitao
    Li, Hao
    Yan, Lvnan
    Fu, Zhiren
    Ye, Qifa
    Chen, Guihua
    Dou, Kefeng
    Lu, Shichun
    Yang, Zhanyu
    Zhu, Zhijun
    Peng, Zhihai
    Zhong, Lin
    [J]. ONCOTARGET, 2017, 8 (34) : 57505 - 57515
  • [4] Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant
    Biselli, Maurizio
    Vitale, Giovanni
    Gramenzi, Annagiulia
    Riili, Anna
    Berardi, Sonia
    Camma, Carlo
    Scuteri, Alessandra
    Morelli, Maria Cristina
    Grazi, Gian Luca
    Pinna, Antonio Daniele
    Andreone, Pietro
    Bernardi, Mauro
    [J]. CLINICAL TRANSPLANTATION, 2009, 23 (02) : 191 - 198
  • [5] Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil
    Barkmann, A
    Nashan, B
    Schmidt, HHJ
    Böker, KHW
    Emmanouilidis, N
    Rosenau, J
    Bahr, MJ
    Hoffmann, MW
    Manns, MP
    Klempnauer, J
    Schlitt, HJ
    [J]. TRANSPLANTATION, 2000, 69 (09) : 1886 - 1890
  • [6] Improvement of Renal Function After Conversion to Mycophenolate Mofetil Combined With Low-Level Calcineurin Inhibitor in Liver Transplant Recipients With Chronic Renal Dysfunction
    Ponton, C.
    Vizcaino, L.
    Tome, S.
    Otero, E.
    Molina, E.
    Castroagudin, J. F.
    Lopez-Lago, A.
    Varo Perez, E.
    [J]. TRANSPLANTATION PROCEEDINGS, 2010, 42 (02) : 656 - 659
  • [7] Evolution of chronic renal dysfunction after conversion from calcineurin inhibitors (CNI) to mycophenolate mofetil monotherapy in liver transplant recipients
    Manrique, Alejandro
    Jimenez, Carlos
    Ortega, Patricia
    Abradelo, Manuel
    Meneu, Juan C.
    Gimeno, Alberto
    Perez, Baltasar
    Calvo, Jorge
    Donat, Maria
    Cambra, Felix
    Lopez, Rose M.
    Morales, Jose M.
    Moreno, Enrique
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 32 - 32
  • [8] A randomised controlled trial of calcineurin inhibitor (CNI) replacement with mycophenolate mofetil and steroids in liver transplant patients with renal dysfunction.
    Day, CP
    O'Grady, J
    Mayer, D
    Simpson, K
    Millson, CE
    Solomons, N
    Duncan, J
    Bechter, M
    Patch, D
    [J]. HEPATOLOGY, 2004, 40 (04) : 547A - 547A
  • [9] Mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction in liver transplant:: A 24-month controlled clinical trial
    Biselli, M.
    Vitale, G.
    Gramenzi, A.
    Riili, A.
    Berardi, S.
    Dazzani, F.
    Camma, C.
    Scuteri, A.
    Morelli, M. C.
    Sama, C.
    Grazi, G. L.
    Pinna, A. D.
    Andreone, F.
    Bernardi, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2007, 39 (10) : A34 - A34
  • [10] Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction:: a randomised controlled study
    Schlitt, HJ
    Barkmann, A
    Böker, KHW
    Schmidt, HHJ
    Emmanouilidis, N
    Rosenau, J
    Bahr, MJ
    Tusch, G
    Manns, MP
    Nashan, B
    Klempnauer, J
    [J]. LANCET, 2001, 357 (9256): : 587 - 591